Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine Monotherapy in Epilepsy
NCT01431963Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of lamotrigine in epilepsy, sponsored by GSK. Started Sep 2011; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01431963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431963.